AKT1 and cancer: Rutin has been shown to target cancer cells by providing anti-inflammatory effects, suppressing pro-inflammatory secretions, altering transcription factors, and modulating cancer signaling pathways (MAPK, PI3K/Akt, epidermal growth factor (EGF), and Wnt/catenin) [12].